0001683168-26-004126.txt : 20260519 0001683168-26-004126.hdr.sgml : 20260519 20260519170209 ACCESSION NUMBER: 0001683168-26-004126 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260519 DATE AS OF CHANGE: 20260519 EFFECTIVENESS DATE: 20260519 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CNS Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001729427 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 822318545 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-584551 FILM NUMBER: 261000070 BUSINESS ADDRESS: STREET 1: 2100 WEST LOOP SOUTH STREET 2: SUITE 900 CITY: HOUSTON STATE: TX ZIP: 77027 BUSINESS PHONE: 1-800-946-9185 MAIL ADDRESS: STREET 1: 2100 WEST LOOP SOUTH STREET 2: SUITE 900 CITY: HOUSTON STATE: TX ZIP: 77027 D 1 primary_doc.xml X0708 D LIVE 0001729427 CNS Pharmaceuticals, Inc. 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX TEXAS 77027 800-946-9185 NEVADA None None Corporation true Rami Levin 2100 West Loop South Suite 900 Houston TX TEXAS 77027 Executive Officer Director Steve O'Loughlin 2100 West Loop South Suite 900 Houston TX TEXAS 77027 Executive Officer Faith Charles 2100 West Loop South Suite 900 Houston TX TEXAS 77027 Director Michal Fisher 2100 West Loop South Suite 900 Houston TX TEXAS 77027 Director Jeffry Keyes 2100 West Loop South Suite 900 Houston TX TEXAS 77027 Director Bettina Cockroft 2100 West Loop South Suite 900 Houston TX TEXAS 77027 Director Amy Mahery 2100 West Loop South Suite 900 Houston TX TEXAS 77027 Director Pharmaceuticals Decline to Disclose 06b false 2026-05-04 false true true false 0 A.G.P./Alliance Global Partners 000008361 None None 88 Post Road West Westport CT CONNECTICUT 06880 DE DELAWARE NY NEW YORK OR OREGON TX TEXAS true 22525000 22525000 0 false 13 1576750 0 Cash payment equal to 7.0% of gross proceeds, plus up to $75,000 reimbursement for fees and expenses and $15,000 for non-accountable expenses. 0 true CNS Pharmaceuticals, Inc. /s/ Rami Levin Rami Levin Chief Executive Officer 2026-05-19